Ho A D, Fiehn W, Hunstein W
Blut. 1984 Jul;49(1):19-28. doi: 10.1007/BF00320380.
Plasma and intracellular levels of lactate dehydrogenase (LDH), phosphohexose isomerase (PHI) and lysozyme activities were investigated in 20 patients with acute myelocytic leukemia (AML), 18 patients with acute lymphatic leukemia (ALL) and 10 patients with chronic myelocytic leukemia in blast transformation (CML/BT). Though the plasma levels of LDH and PHI in all patients with acute leukemia were elevated as compared to control persons there was no distinctive pattern which could be of use in the classification of acute leukemia. On the other hand the intracellular levels of these enzymes could be of value in classifying acute leukemia. The leukemic lymphoblasts were characterized by low levels of PHI and lysozyme as compared to leukemic myeloblasts or to normal lymphocytes (p less than 0.01). The LDH/PHI ratio is also significantly higher in leukemic lymphoblasts than in leukemic myeloblasts or in normal lymphocytes (p always less than 0.01). These characteristics might also be made use of in identifying the blasts of CML/BT als "lymphoid" or "myeloid" in corresponding cases.
对20例急性髓细胞白血病(AML)患者、18例急性淋巴细胞白血病(ALL)患者和10例急变期慢性髓细胞白血病(CML/BT)患者的血浆和细胞内乳酸脱氢酶(LDH)、磷酸己糖异构酶(PHI)水平及溶菌酶活性进行了研究。尽管与对照组相比,所有急性白血病患者的血浆LDH和PHI水平均升高,但没有可用于急性白血病分类的独特模式。另一方面,这些酶的细胞内水平在急性白血病分类中可能有价值。与白血病髓母细胞或正常淋巴细胞相比,白血病淋巴母细胞的PHI和溶菌酶水平较低(p<0.01)。白血病淋巴母细胞的LDH/PHI比值也显著高于白血病髓母细胞或正常淋巴细胞(p始终<0.01)。在相应病例中,这些特征也可用于识别CML/BT的母细胞是“淋巴样”还是“髓样”。